Headlines

Eton Pharmaceuticals And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Eton Pharmaceuticals (ETON), Citizens Community Bancorp (CZWI), ACM Research (ACMR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Eton Pharmaceuticals (ETON)

50.2% sales growth and 6.83% return on equity

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Earnings Per Share

As for profitability, Eton Pharmaceuticals has a trailing twelve months EPS of $0.03.

PE Ratio

Eton Pharmaceuticals has a trailing twelve months price to earnings ratio of 121. Meaning, the purchaser of the share is investing $121 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.83%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 138.9% and positive 200% for the next.

Sales Growth

Eton Pharmaceuticals’s sales growth is negative 26.6% for the present quarter and 50.2% for the next.

Moving Average

Eton Pharmaceuticals’s value is above its 50-day moving average of $3.49 and below its 200-day moving average of $3.90.

2. Citizens Community Bancorp (CZWI)

17.2% sales growth and 7.99% return on equity

Citizens Community Bancorp, Inc. operates as a bank holding company for Citizens Community Federal N.A. that provides various traditional community banking services to businesses, agricultural operators, and consumers. The company accepts various deposit products, including demand deposits, savings and money market accounts, and certificates of deposit. It also offers various loan products comprising commercial real estate, commercial and industrial, agricultural real estate, agricultural operating, and consumer loans; and residential mortgages and home equity lines-of-credit. In addition, the company provides a portfolio of investments, such as mortgage-backed, corporate asset-backed, U.S. Government sponsored agency, corporate debt, and trust preferred securities. It operates through a network of 25 branch locations in Wisconsin and Minnesota. The company was founded in 1938 and is based in Eau Claire, Wisconsin.

Earnings Per Share

As for profitability, Citizens Community Bancorp has a trailing twelve months EPS of $1.29.

PE Ratio

Citizens Community Bancorp has a trailing twelve months price to earnings ratio of 10.15. Meaning, the purchaser of the share is investing $10.15 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.99%.

Yearly Top and Bottom Value

Citizens Community Bancorp’s stock is valued at $13.09 at 20:22 EST, below its 52-week high of $13.34 and way above its 52-week low of $8.47.

3. ACM Research (ACMR)

15.7% sales growth and 12.26% return on equity

ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the SAPS, TEBO, ULTRA C, ULTRA Fn, Ultra ECP, Ultra ECP map, and Ultra ECP ap trademarks through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.

Earnings Per Share

As for profitability, ACM Research has a trailing twelve months EPS of $1.31.

PE Ratio

ACM Research has a trailing twelve months price to earnings ratio of 13.25. Meaning, the purchaser of the share is investing $13.25 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.26%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 27.1% and a negative 21.1%, respectively.

Sales Growth

ACM Research’s sales growth is 41.1% for the present quarter and 15.7% for the next.

Previous days news about ACM Research(ACMR)

  • ACM research's (acmr) Q2 earnings coming up: should you buy or sell?. According to Zacks on Tuesday, 6 August, "However, ACM Research faces significant challenges from macroeconomic uncertainties and intensifying competition in the semiconductor industry.", "Now, let us look at the value that ACM Research offers to its investors at current levels."

4. Nelnet (NNI)

10.7% sales growth and 3.16% return on equity

Nelnet, Inc. engages in loan servicing, communications, education technology, services, and payment processing businesses worldwide. Its Loan Servicing and Systems segment provides loan conversion, application processing, borrower updates, customer service, payment processing, due diligence procedures, funds management reconciliation, and claim processing services. This segment also offers student loan servicing software; business process outsourcing services specialized in contact center management, such as inbound calls, outreach campaigns and sales, and interacting with customers through multi-channels. The company's Education Technology, Services, and Payment Processing segment provides financial management services; school information system software; website design and cost effective admissions software; FACTS Giving, a donation platform; and customized professional development and coaching services, educational instruction services, and technology products that aid in teacher and student evaluations. It also offers tuition payment plans, and service and technology for student billings, payments, and refunds; solutions for in-person, online, and mobile payment experiences on campus; payment processing services, such as credit card and electronic transfer; faith community, giving, and learning management services and technologies; and an integrated commerce payment platform, financial management, and tuition payment plan services, as well as a school management platform that provides administrative, information and financial management, and communication functions for K-12 schools. Its Communications segment provides fiber optic service to homes and businesses for internet, television, and telephone services. The Company's Asset Generation and Management segment acquires, manages, and owns loan assets. Its Nelnet Bank segment operates as an internet industrial bank. The company was founded in 1978 and is headquartered in Lincoln, Nebraska.

Earnings Per Share

As for profitability, Nelnet has a trailing twelve months EPS of $3.71.

PE Ratio

Nelnet has a trailing twelve months price to earnings ratio of 29.87. Meaning, the purchaser of the share is investing $29.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.16%.

Yearly Top and Bottom Value

Nelnet’s stock is valued at $110.80 at 20:22 EST, below its 52-week high of $112.57 and way above its 52-week low of $81.67.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 31, 2024, the estimated forward annual dividend rate is 1.12 and the estimated forward annual dividend yield is 1.02%.

Sales Growth

Nelnet’s sales growth is negative 29.8% for the ongoing quarter and 10.7% for the next.

Leave a Reply

Your email address will not be published. Required fields are marked *